A group of lawmakers are urging President
Trump should use his deal-making skills to “flat out reject any request to end negotiations from giant pharmaceutical makers that have spent decades putting profits over patients,” Democratic Senators
“There is no legal basis for any pause, and allowing giant pharmaceutical companies to pressure you into one would dramatically increase costs for over 60 ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
